Originally posted by fkrueger
View Post
Unconfigured Ad
Collapse
X
-
You should ask whoever is doing the sequencing for you what to expect in terms of read quality towards the end of the reads. When we were sequencing with the GA, we had extremely high quality all the way to base 100 -- often a median > Q35.
With the hiseqs they have been optimizing some things. We have had some runs "fail"... but they were eventually redone, and typically we have quality >Q30 at read 100. Especially since you expect to have many mismatches, I think that the value of longer reads would be very high for your application. You can always quality trim your reads using a tool like fastx (fastq_quality_trimmer). Even when the quality trails off at the end of a run, you will get a large fraction of the reads that don't need to be trimmed.
Comment
-
Thanks All for the informative answers.
Hi all I have another Question regarding this approach:
Q2) Secondly a concern some of my colleagues have highlighted is that using a PCR approach we would get over-representation of the start and end of the reads (i.e. the start and end of the desired 200bp amplicon) and a much lower if not absent coverage of the middle portion. Would anyone have any comments as to whether this would be the case and if so are there ways around this?
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment